Position paper: Breast cancer screening, diagnosis, and treatment in Denmark

References

• NORDCAN database [Internet]. [cited 2012 Mar 8]. Available from: http//www-dep.iarc.fr/nordcan.htm.
   Google Scholar
• Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 2011; 377:127–38.
   PubMed Web of Science ®Google Scholar
• Mouridsen HT, Bjerre KD, Christiansen P, Jensen M-B, Møller S. Improvement of prognosis in breast cancer in Denmark 1977–2006, based on the nationwide reporting to the DBCG Registry. Acta Oncol 2008;47:525–36.
   PubMed Web of Science ®Google Scholar
• Christensen LH, Engholm G, Ceberg J, Hein S, Perfekt R, Tange UB, et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? – a population-based study. Eur J Cancer 2004;40:1233–43.
   PubMed Web of Science ®Google Scholar
• Jensen AR, Garne JP, Storm HH, Engholm G, Möller T, Overgaard J. Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?Acta Oncol 2004;43:719–26.
   PubMed Web of Science ®Google Scholar
• Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: A population-based study. Br J Cancer 2013;108:1195–208.
   PubMed Web of Science ®Google Scholar
• Jensen A, Olsen AH, von Euler-Chelpin M, Helle Njor S, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere?Int J Cancer 2005;113:464–70.
   PubMed Web of Science ®Google Scholar
• Domingo L, Jacobsen KK, von Euler-Chelpin M, Vejborg I, Schwartz W, Sala M, et al. Seventeen-years overview of breast cancer inside and outside screening in Denmark. Acta Oncol 2013;52:48–56.
   PubMed Web of Science ®Google Scholar
• Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition – summary document. Ann Oncol 2008;19:614–22.
   PubMed Web of Science ®Google Scholar
• Vejborg I, Mikkelsen EM, Schwartz W, Bak M, Lernevall A, Borg Mogensen N, et al. [Danish Quality Database for Mammography Screening]. Ugeskr Laeger 2012;174:2533.
   PubMedGoogle Scholar
• IARC handbooks of cancer prevention. Vol. 7: Breast cancer screening. Lyon: IARC Press; 2002.
   Google Scholar
• Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727–37, W237–42.
   PubMed Web of Science ®Google Scholar
• Anonymous. The benefits and harms of breast cancer screening: An independent review. Lancet 2012;380:1778–86.
   PubMed Web of Science ®Google Scholar
• Sarkeala T, Heinävaara S, Anttila A. Breast cancer mortality with varying invitational policies in organised mammography. Br J Cancer 2008;98:641–5.
   PubMed Web of Science ®Google Scholar
• Jonsson H, Nyström L, Törnberg S, Lundgren B, Lenner P. Service screening with mammography. Long-term effects on breast cancer mortality in the county of Gävleborg, Sweden. Breast 2003;12:183–93.
   PubMed Web of Science ®Google Scholar
• Jonsson H, Bordás P, Wallin H, Nyström L, Lenner P. Service screening with mammography in Northern Sweden: Effects on breast cancer mortality – an update. J Med Screen 2007;14:87–93.
   PubMed Web of Science ®Google Scholar
• Kalager M, Zelen M, Langmark F, Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203–10.
   PubMed Web of Science ®Google Scholar
• Lynge E, Braaten T, Njor SH, Olsen AH, Kumle M, Waaseth M, et al. Mammography activity in Norway 1983 to 2008. Acta Oncol 2011;50:1062–7.
   PubMed Web of Science ®Google Scholar
• Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: Cohort study. Br Med J 2005;330:220.
   PubMed Web of Science ®Google Scholar
• Jorgensen KJ, Zahl P-H, Gotzsche PC. Breast cancer mortality in organised mammography screening in Denmark: Comparative study. Br Med J 2010;340:c1241.
   Web of Science ®Google Scholar
• Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E. Breast cancer incidence after the introduction of mammography screening: What should be expected?Cancer 2006; 106:1883–90.
   PubMed Web of Science ®Google Scholar
• Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: Follow-up study. Br Med J 2006;332:689–92.
   PubMed Web of Science ®Google Scholar
• Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137:305–12.
   PubMed Web of Science ®Google Scholar
• Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst 2000;92: 1490–9.
   PubMed Web of Science ®Google Scholar
• Njor SH, Garne JP, Lynge E. Over-diagnosis estimate from The Independent UK Panel on Breast Cancer Screening is based on unsuitable data. J Med Screen 2013;20:104–5.
   PubMed Web of Science ®Google Scholar
• De Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011;33:111–21.
   PubMed Web of Science ®Google Scholar
• Waller M, Moss S, Watson J, Møller H. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev 2007;16:2257–61.
   PubMed Web of Science ®Google Scholar
• Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25–30.
   PubMed Web of Science ®Google Scholar
• Paci E, Miccinesi G, Puliti D, Baldazzi P, De Lisi V, Falcini F, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res 2006; 8:R68.
   Web of Science ®Google Scholar
• Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45:3166–71.
   PubMed Web of Science ®Google Scholar
• Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006;12:338–42.
   PubMed Web of Science ®Google Scholar
• Jørgensen KJ, Zahl P-H, Gøtzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health 2009;9:36.
   PubMedGoogle Scholar
• Njor SH, Olsena. H, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E: Overdiagnosis in screening mammography in Denmark: Population based cohort study. Br Med J 2013;346:f1064.
   PubMed Web of Science ®Google Scholar
• Laenkholm A-V, Jensen M-B, Kroman N, Rank F. Breast cancer in situ. From pre-malignant lesion of uncertain significance to well-defined non-invasive malignant lesion. The Danish Breast Cancer Cooperative Group Register 1977–2007 revisited. Acta Oncol 2008;47:765–71.
   PubMed Web of Science ®Google Scholar
• Paci E. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012; 19(Suppl 1):5–13.
   PubMed Web of Science ®Google Scholar
• Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998–2005.
   PubMed Web of Science ®Google Scholar
• Zahl P-H, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008;168:2311–6.
   PubMed Web of Science ®Google Scholar
• Richards C. Spontaneous regression of breast cancer (editor's correspondence). Arch Intern Med 2011;169:996.
   Web of Science ®Google Scholar
• Larsen SU, Rose C. Spontaneous remission of breast cancer. A literature review. Ugeskr Laeger 1999;161:4001–4.
   PubMedGoogle Scholar
• Christensen LH, Andersson M, Storm HH. [Untreated breast cancer in Denmark 1978–1995]. Ugeskr Laeger 2001;163:2774–8.
   PubMedGoogle Scholar
• Zahl P-H, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: A cohort study. Lancet Oncol 2011; 12:1118–24.
   PubMed Web of Science ®Google Scholar